Can very high-dose anti-tumor necrosis factor blockade at onset of rheumatoid arthritis produce long-term remission?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Can very high-dose anti-tumor necrosis factor blockade at onset of rheumatoid arthritis produce long-term remission?

Published:2002-07 Issue:7 Volume:46 Page:1971-1972
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Conaghan Philip G.,Quinn Mark A.,O'Connor Philip,Wakefield Richard J.,Karim Zunaid,Emery Paul

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference9 articles.

1. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

2. Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

3. Tumor necrosis factor. In: editor. The Cytokine handbook. 3rd ed. San Diego (CA): Academic Press; 1998. p. 517-48.

4. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

5. Measurement of patient outcome in arthritis

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial;Trials;2014-11-08

2. Infliximab has no apparent effect in the inner ear hearing function of patients with rheumatoid arthritis and ankylosing spondylitis;Clinical Rheumatology;2014-04-27

3. Biological therapy for rheumatoid arthritis: where are we now?;British Journal of Hospital Medicine;2012-01

4. Relationship between early bone mineral density changes and long-term function and radiographic progression in rheumatoid arthritis;Arthritis Care & Research;2011-12-28

5. Infliximab: 12 years of experience;Arthritis Research & Therapy;2011-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3